reportlinker.com/p0203082/The-Pharmaceutical-Market-Russia.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Espicom’s highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
EXECUTIVE SUMMARY 1
Snapshot: Strategic Espicom Analysis 2
Snapshot: Key Data Projections 3
MACROENVIRONMENT 4
POLITICAL 4
ECONOMIC6
Projections 6
LEGAL7
Patent Law 7
USTR Status7
WTO Accession 7
Bilateral IPR Agreement7
DEMOGRAPHIC 8
Projections 8
Demographic Indicators9
Births 9
Deaths 9
Infant Deaths 9
Life Expectancy at Birth 9
EPIDEMIOLOGY 10
DISEASE BURDEN 10
Leading Causes of Mortality 10
DISEASE PREVALENCE11
Communicable Diseases 11
HIV/AIDS 11
Non-Communicable Diseases 12
HEALTHCARE – ACCOMPANYING HEALTH STATISTICS 13
ORGANISATION 13
Fundamentals of Protection of Public Health in the Russian Federation Bill 13
Regional Healthcare Modernisation Programme 14
Concept for the Development of the Healthcare Sector until 2020 14
National Health Project 14
EXPENDITURE 15
Projections 15
Social Security16
New Legislation 16
INFRASTRUCTURE 17
Hospital Infrastructure17
Outpatient Infrastructure 18
SERVICES 19
Hospital Inpatient Services 19
Outpatient Services20
WORKFORCE 21
Projections 21
Physicians 22
REGULATORY AFFAIRS 23
NATIONAL AUTHORITY 23
REGULATORY DEVELOPMENTS 23
MARKETING REGISTRATION 24
IMPORT REGULATIONS 24
PROMOTION 25
PRICING & REIMBURSEMENT 26
PRICING 26
New Methods for Setting Retail Prices of Medicines27
Registration of Maximum Prices 27
Price Freezes 27
REIMBURSEMENT 28
DLO 28
DLO Budget 28
DLO Procurement28
Vital & Essential Medicines List 29
OMI’s Prescription Drug Reimbursement29
DISTRIBUTION CHANNELS 30
DRUG WHOLESALING 30
Leading Wholesalers 30
Alliance Healthcare30
Katren 30
Protek 30
Shreya Corporation 31
SIA International 31
DRUG RETAILING31
Leading Pharmacy Chains 31
Pharmacy Chain 36 6 31
Rigla 32
MARKET ANALYSIS 33
SIZE 33
Projections 33
Historical Figures 35
Current Structure 36
Pharmacy Sector 36
Hospital Sector 39
DLO Sector 41
PRODUCT DEVELOPMENT 42
Clinical Trials 42
MANUFACTURING 43
Pharma 2020 44
TRADE 46
Exports 46
Imports 49
Balance of Trade 53
COMPETITION 54
TRADE ASSOCIATION 55
AIPM 55
TRADE FAIRS 56
Hospital 56
Pharmtech 201256
COMPANY INTELLIGENCE 57
Foreign Producer 57
Sanofi57
Local Producers57
Akrikhin 57
Biosintez 58
JSC Farmacon 58
Pharmstandard 59
Pharm-Sintez 62
Sotex 62
Valenta62
Veropharm63
Yugrafarm 63
Competitive Strategies64
OTC PHARMACEUTICALS 66
MARKET SIZE 66
COMPETITION 66
Competitive Strategies66
GENERIC PHARMACEUTICALS 67
MARKET SIZE 67
COMPETITION 67
Foreign Generic Producers67
KRKA 68
STADA CIS 69
Competitive Strategies70
BIOLOGICS & BIOSIMILARS 71
COMPETITION 71
Binnopharm71
Biocad 71
Generium 72
Microgen73
Pushchino Scientific Centre 73
CONCLUSIONS: OPPORTUNITIES & CHALLENGES 74
Strategic Espicom Analysis 74
MACROENVIRONMENT 74
EPIDEMIOLOGY 74
HEALTHCARE 74
REGULATORY AFFAIRS 75
PRICING & REIMBURSEMENT75
DISTRIBUTION CHANNELS 76
MARKET 76
COMPETITION 77
OTC PHARMACEUTICALS 77
GENERIC PHARMACEUTICALS 77
BIOLOGICS & BIOSIMILARS77
Radar Analysis 79
SWOT Analysis 79
DIRECTORY 80
COMPANY INTELLIGENCE 80
Foreign Pharmaceutical Producer80
Local Pharmaceutical Producers80
Foreign Generic Producers80
Biologic & Biosimilar Producers 80
GOVERNMENT ORGANISATIONS81
TRADE ASSOCIATIONS 81
Espicom Analysis of the Pharmaceutical Market, 2012 2
Key Data Projections, 2011-2016 3
Political Landscape, 2012 5
Regional Ranking of Projected Economies, 2016 6
Projected Economy, 2011-2016 6
Regional Ranking of Projected Demographics, 2016 8
Projected Demographics, 2011-2016 8
Demographic Indicators, 2001-2009 9
Leading Causes of Death, 2007-2009 10
Morbidity by Diagnosis, 2007-2009 (000s)12 Regional Ranking of Projected Health Expenditure, 2016 15
Projected Health Expenditure, 2011-2016 15
Hospitals & Beds, 1990-2009 17
Public Outpatient Care Facilities, 1995-2008 18
Public Inpatient Activity, 2002-2008 19
Public Hospital Discharges by Group of Diseases, 2005-2008 19
Day Surgery Discharges by Group of Diseases, 2005-2008 20
Regional Ranking of Projected Physicians, 2016 21
Projected Physicians, 2011-2016 21
Pharmacy Chain 36 6 Financial Results, 2002-2010 (US$ Millions) 31
Regional Ranking of Projected Pharmaceutical Markets at Retail Prices, 2016 33
Projected Pharmaceutical Market at Retail Prices, 2011-2016 33
Historical Pharmaceutical Market at Retail Prices, 1995-2010 35
Pharmacy Sales at Retail Prices, 2003-2011 36
Pharmacy Sales at Wholesale Prices, 2003-2011 36
Pharmacy Sales Volume, 2006-2011 36
Pharmacy Sales Value by Leading Manufacturer, 2003-September 2011 (%) 37
Moscow City Pharmacy Sales at Retail Prices, 2004-2011 37
Moscow City Pharmacy Sales at Wholesale Prices, 2004-2011 38
Moscow City Pharmacy Sales Volume, 2007-2011 38
St Petersburg City Pharmacy Sales at Retail Prices, 2004-2011 38
St Petersburg City Pharmacy Sales at Wholesale Prices, 2004-2011 39
St Petersburg City Pharmacy Sales Volume, 2007-2011 39
Hospital Purchases at Wholesale Prices, 2003-2011 39
Hospital Purchases Volume, 2006-2011 40 Moscow City Hospital Purchases at Wholesale Prices, 2007-2011 40
Moscow City Hospital Purchases Volume, 2007-2011 40
St Petersburg City Hospital Purchases at Wholesale Prices, 2007-2011 41
St Petersburg City Hospital Purchases Volume, 2007-2011 41
DLO Sales at Wholesale Prices, 2006-2011 41
DLO Sales Volume, 2006-2011 42
Production Value at Manufacturers’ Prices, 2004-2011 43
Production Value by Leading Domestic Companies, April 2011-November 2011 (US$ Million) 44
Pharmaceutical Exports by Category, 1995-2010 (US$000s)46
Pharmaceutical Exports by Country/Region, 2010 (US$000s) 48
Pharmaceutical Imports by Category, 1995-2010 (US$000s) 49
Imports of Raw Materials by Country/Region, 2010 (US$000s) 51
Imports of Antisera & Vaccines by Country/Region, 2010 (US$000s) 51
Imports of Medicaments by Country/Region, 2010 (US$000s) 52
Balance of Pharmaceutical Trade, 1995-2010 (US$000s) 53
Top Pharmaceutical Companies by Sales, 2009-2010 (%) 54
AIPM Members, 2011 55
Pharmstandard Financial Results, 2004-2010 (R Millions) 59
Pharmstandard Pharmaceutical Sales by Type, 2007-2010 (R Millions)60
Pharmstandard Top 10 OTCs, 2009-2010 60
Pharmstandard Production by Facility, 2009-2010 61
Veropharm’s Financial Results, 2005-2010 (US$ Million) 63
Top Ten Manufacturers, Trade Names and ATG Groups in the OTC Market, 2009 66
Gedeon Richter Russia Revenue, 2007-2010 (Million Euros) 67
KRKA’s Russia Revenue, 2007-2010 (Million Euros) 68
STADA Russian Revenues by Type, 2005-2010 (Million Euros) 69
Espicom Analysis of the Pharmaceutical Market, 2012 78
SWOT Analysis of the Pharmaceutical Market, 2012 79
Regional Comparison of Top 6 Projected Pharmaceutical Markets at Retail Prices, 2016 34
Regional Comparison of Projected Pharmaceutical Market Share at Retail Prices, 2016 34
Historical Pharmaceutical Market at Retail Prices, 1995-2010 35
Pharmaceutical Imports, 1995-2010 (US$ Millions) 49
Pharmaceutical Imports by Country/Region, 2010 (%) 50
Balance of Pharmaceutical Trade, 1995-2010 (US$ Millions) 53
Radar Graph of the Pharmaceutical Market, 2012 79
SOURCE Reportlinker